Neurotransmitters: emerging targets in cancer

Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the stimulatory or inhibitory neuronal functions through binding to their respective receptors. In the past decades, many novel discoveries come to light elucidating the regulatory roles of neurotransmitters in the...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 39; no. 3; pp. 503 - 515
Main Authors Jiang, Shu-Heng, Hu, Li-Peng, Wang, Xu, Li, Jun, Zhang, Zhi-Gang
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 16.01.2020
Nature Publishing Group
Subjects
13/21
38/39
42/47
45/41
631/67/327
631/80/86/2363
Angiogenesis
Animals
Antineoplastic Agents - therapeutic use
Antitumor activity
Apoptosis
B cells
Cancer
Carcinogenesis - drug effects
Carcinogenesis - pathology
Cell Biology
Cell proliferation
Development and progression
Disease Models, Animal
Endothelial cells
Human Genetics
Humans
Inflammation
Inflammation - drug therapy
Inflammation - immunology
Inflammation - pathology
Internal Medicine
Medicine
Medicine & Public Health
Mice
Neoplasms - blood supply
Neoplasms - drug therapy
Neoplasms - immunology
Neoplasms - pathology
Neovascularization, Pathologic - drug therapy
Neovascularization, Pathologic - immunology
Neovascularization, Pathologic - pathology
Neurophysiology
Neurotransmitter Agents - antagonists & inhibitors
Neurotransmitter Agents - metabolism
Neurotransmitters
Oncology
Physiological aspects
Receptors, Neurotransmitter - antagonists & inhibitors
Receptors, Neurotransmitter - metabolism
Review Article
Signal transduction
Signal Transduction - drug effects
Tumor Microenvironment - drug effects
Tumor Microenvironment - immunology
Tumorigenesis
Online AccessGet full text

Cover

Abstract Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the stimulatory or inhibitory neuronal functions through binding to their respective receptors. In the past decades, many novel discoveries come to light elucidating the regulatory roles of neurotransmitters in the physiological and pathological functions of tissues and organs. Notably, emerging data suggest that cancer cells take advantage of the neurotransmitters-initiated signaling pathway to activate uncontrolled proliferation and dissemination. In addition, neurotransmitters can affect immune cells and endothelial cells in the tumor microenvironment to promote tumor progression. Therefore, a better understanding of the mechanisms underlying neurotransmitter function in tumorigenesis, angiogenesis, and inflammation is expected to enable the development of the next generation of antitumor therapies. Here, we summarize the recent important studies on the different neurotransmitters, their respective receptors, target cells, as well as pro/antitumor activity of specific neurotransmitter/receptor axis in cancers and provide perspectives and insights regarding the rationales and strategies of targeting neurotransmitter system to cancer treatment.
AbstractList Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the stimulatory or inhibitory neuronal functions through binding to their respective receptors. In the past decades, many novel discoveries come to light elucidating the regulatory roles of neurotransmitters in the physiological and pathological functions of tissues and organs. Notably, emerging data suggest that cancer cells take advantage of the neurotransmitters-initiated signaling pathway to activate uncontrolled proliferation and dissemination. In addition, neurotransmitters can affect immune cells and endothelial cells in the tumor microenvironment to promote tumor progression. Therefore, a better understanding of the mechanisms underlying neurotransmitter function in tumorigenesis, angiogenesis, and inflammation is expected to enable the development of the next generation of antitumor therapies. Here, we summarize the recent important studies on the different neurotransmitters, their respective receptors, target cells, as well as pro/antitumor activity of specific neurotransmitter/receptor axis in cancers and provide perspectives and insights regarding the rationales and strategies of targeting neurotransmitter system to cancer treatment.Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the stimulatory or inhibitory neuronal functions through binding to their respective receptors. In the past decades, many novel discoveries come to light elucidating the regulatory roles of neurotransmitters in the physiological and pathological functions of tissues and organs. Notably, emerging data suggest that cancer cells take advantage of the neurotransmitters-initiated signaling pathway to activate uncontrolled proliferation and dissemination. In addition, neurotransmitters can affect immune cells and endothelial cells in the tumor microenvironment to promote tumor progression. Therefore, a better understanding of the mechanisms underlying neurotransmitter function in tumorigenesis, angiogenesis, and inflammation is expected to enable the development of the next generation of antitumor therapies. Here, we summarize the recent important studies on the different neurotransmitters, their respective receptors, target cells, as well as pro/antitumor activity of specific neurotransmitter/receptor axis in cancers and provide perspectives and insights regarding the rationales and strategies of targeting neurotransmitter system to cancer treatment.
Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the stimulatory or inhibitory neuronal functions through binding to their respective receptors. In the past decades, many novel discoveries come to light elucidating the regulatory roles of neurotransmitters in the physiological and pathological functions of tissues and organs. Notably, emerging data suggest that cancer cells take advantage of the neurotransmitters-initiated signaling pathway to activate uncontrolled proliferation and dissemination. In addition, neurotransmitters can affect immune cells and endothelial cells in the tumor microenvironment to promote tumor progression. Therefore, a better understanding of the mechanisms underlying neurotransmitter function in tumorigenesis, angiogenesis, and inflammation is expected to enable the development of the next generation of antitumor therapies. Here, we summarize the recent important studies on the different neurotransmitters, their respective receptors, target cells, as well as pro/antitumor activity of specific neurotransmitter/receptor axis in cancers and provide perspectives and insights regarding the rationales and strategies of targeting neurotransmitter system to cancer treatment.
Audience Academic
Author Li, Jun
Wang, Xu
Zhang, Zhi-Gang
Jiang, Shu-Heng
Hu, Li-Peng
Author_xml – sequence: 1
  givenname: Shu-Heng
  surname: Jiang
  fullname: Jiang, Shu-Heng
  organization: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
– sequence: 2
  givenname: Li-Peng
  surname: Hu
  fullname: Hu, Li-Peng
  organization: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
– sequence: 3
  givenname: Xu
  surname: Wang
  fullname: Wang, Xu
  organization: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
– sequence: 4
  givenname: Jun
  surname: Li
  fullname: Li, Jun
  organization: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
– sequence: 5
  givenname: Zhi-Gang
  orcidid: 0000-0001-8965-223X
  surname: Zhang
  fullname: Zhang, Zhi-Gang
  email: zzhang@shsci.org
  organization: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31527667$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rHSEYhaWkNDdpf0A35UI33Zi8fo_dhdAvCOkmWYvXeWcwzDipOov--3i5CaGhLYKCPOe8es4JOUpLQkLeMzhjILrzIpnoOgrMUgagKbwiGyaNpkpZeUQ2YBVQywU_Jiel3AGAscDfkGPBFDdamw2h17jmpWafyhxrxVw-b3HGPMY0bqvPI9ayjWkbfAqY35LXg58Kvns8T8nt1y83l9_p1c9vPy4vrmiQwlbKENVgDex20oJQA-9154VUWnHei0EECVwMRu9C27k0PUoIzEsWOGhlUJySTwff-7z8WrFUN8cScJp8wmUtjnPLrTVG24Z-fIHeLWtO7XWOCymYUUapZ2r0E7qYhv2Xw97UXWjGpG4pdY06-wvVVo9zDC37Ibb7PwQfHoevuxl7d5_j7PNv95RvA8wBCHkpJePgQqy-xiU15zg5Bm7fpDs06VqTbt-kg6ZkL5RP5v_T8IOmNDaNmJ-z-LfoAdEcqzY
CitedBy_id crossref_primary_10_1016_j_apsusc_2023_158698
crossref_primary_10_1172_JCI160152
crossref_primary_10_1021_acsbiomaterials_2c01186
crossref_primary_10_1016_j_neulet_2024_137816
crossref_primary_10_3389_fcimb_2022_881071
crossref_primary_10_1016_j_jddst_2023_104276
crossref_primary_10_1158_1541_7786_MCR_23_0513
crossref_primary_10_1038_s41392_024_01761_z
crossref_primary_10_1002_adbi_202200046
crossref_primary_10_3390_diagnostics14141517
crossref_primary_10_1089_ars_2021_0243
crossref_primary_10_1158_2326_6066_CIR_20_1043
crossref_primary_10_1038_s41556_021_00839_y
crossref_primary_10_1371_journal_pone_0274814
crossref_primary_10_3390_cells13151279
crossref_primary_10_3389_fcell_2022_980219
crossref_primary_10_1016_j_ymthe_2022_03_012
crossref_primary_10_3389_fonc_2020_572722
crossref_primary_10_3390_cancers14102544
crossref_primary_10_1186_s40164_024_00500_y
crossref_primary_10_1016_j_rechem_2021_100193
crossref_primary_10_1016_j_lfs_2024_123067
crossref_primary_10_1016_j_apsb_2025_03_025
crossref_primary_10_1172_JCI176454
crossref_primary_10_3389_fimmu_2023_1118637
crossref_primary_10_14233_ajchem_2023_27588
crossref_primary_10_1186_s13578_023_01008_4
crossref_primary_10_1245_s10434_022_12573_2
crossref_primary_10_1016_j_cbpa_2023_102310
crossref_primary_10_3389_fimmu_2024_1284629
crossref_primary_10_3389_fimmu_2023_1254054
crossref_primary_10_34014_2227_1848_2024_1_184_196
crossref_primary_10_3390_cancers12113096
crossref_primary_10_3390_ncrna8030033
crossref_primary_10_3390_ijms222313085
crossref_primary_10_1016_j_isci_2022_104498
crossref_primary_10_1016_j_gene_2024_149135
crossref_primary_10_1080_00207454_2022_2107514
crossref_primary_10_3389_fgene_2023_1062052
crossref_primary_10_1016_j_pharmthera_2024_108624
crossref_primary_10_3390_ijms25095033
crossref_primary_10_1016_j_lfs_2020_118826
crossref_primary_10_1021_acs_chemrev_1c00746
crossref_primary_10_3390_jcm13185616
crossref_primary_10_5812_ijcm_119130
crossref_primary_10_1016_j_neuroscience_2024_12_014
crossref_primary_10_1016_j_canlet_2022_215610
crossref_primary_10_1016_j_ccr_2021_213784
crossref_primary_10_1038_s41388_020_01395_9
crossref_primary_10_3389_fimmu_2022_1066359
crossref_primary_10_3390_cancers12061475
crossref_primary_10_3389_fcell_2022_887076
crossref_primary_10_3389_fphys_2022_839437
crossref_primary_10_3390_cancers15113040
crossref_primary_10_1021_acssensors_2c00474
crossref_primary_10_1038_s41596_021_00538_w
crossref_primary_10_1016_j_aca_2024_342998
crossref_primary_10_1097_MD_0000000000030469
crossref_primary_10_1016_j_bioorg_2024_107296
crossref_primary_10_3390_cancers13174471
crossref_primary_10_1007_s00432_021_03814_0
crossref_primary_10_1007_s13402_022_00723_3
crossref_primary_10_1016_j_biopha_2024_117007
crossref_primary_10_3390_cancers14163970
crossref_primary_10_1016_j_ejmech_2024_116360
crossref_primary_10_1038_s41556_021_00820_9
crossref_primary_10_3390_cancers15153898
crossref_primary_10_3390_ijms22042042
crossref_primary_10_3390_ijms25116237
crossref_primary_10_1021_acs_analchem_2c00460
crossref_primary_10_3390_ijms25116239
crossref_primary_10_1186_s12885_021_07928_z
crossref_primary_10_1007_s12672_024_01205_8
crossref_primary_10_3390_cancers14081979
crossref_primary_10_1016_j_heliyon_2024_e31444
crossref_primary_10_3390_cancers17020286
crossref_primary_10_1016_j_aca_2022_339772
crossref_primary_10_1007_s12094_021_02571_3
crossref_primary_10_1242_jcs_257337
crossref_primary_10_3389_fonc_2022_800499
crossref_primary_10_3389_fcell_2023_1202193
crossref_primary_10_1002_cac2_12103
crossref_primary_10_1016_j_microc_2024_110616
crossref_primary_10_3390_bios13090892
crossref_primary_10_1038_s41416_022_02132_7
crossref_primary_10_1186_s13046_023_02728_8
crossref_primary_10_3390_biomedicines9121927
crossref_primary_10_1007_s12264_023_01082_1
crossref_primary_10_1523_JNEUROSCI_1062_19_2020
crossref_primary_10_3389_fphar_2020_00152
crossref_primary_10_1016_j_jconrel_2022_09_049
crossref_primary_10_1038_s41388_022_02479_4
crossref_primary_10_1016_j_bbcan_2020_188411
crossref_primary_10_3389_fimmu_2025_1528363
crossref_primary_10_1039_D2FO03477H
crossref_primary_10_1016_j_jep_2023_117069
crossref_primary_10_1007_s13402_023_00894_7
crossref_primary_10_3389_fphar_2024_1468920
crossref_primary_10_1155_2022_9595704
crossref_primary_10_1002_JLB_4CE0421_202R
crossref_primary_10_1007_s13402_023_00857_y
crossref_primary_10_1080_14789450_2023_2174851
crossref_primary_10_3389_fcell_2021_699487
crossref_primary_10_3390_jpm11100954
crossref_primary_10_1038_s41388_022_02584_4
crossref_primary_10_1007_s12264_023_01126_6
crossref_primary_10_2147_PGPM_S411862
crossref_primary_10_3389_fcell_2022_896147
crossref_primary_10_1089_bioe_2020_0051
crossref_primary_10_1016_j_bioorg_2022_106306
crossref_primary_10_3390_ijms232112829
crossref_primary_10_3389_fcell_2020_586757
crossref_primary_10_1007_s10072_023_07010_5
crossref_primary_10_1158_1541_7786_MCR_24_0785
crossref_primary_10_1039_D3TB00657C
crossref_primary_10_3390_molecules29235593
crossref_primary_10_1007_s13402_023_00901_x
crossref_primary_10_1016_j_tranon_2020_100861
crossref_primary_10_1167_iovs_62_6_18
crossref_primary_10_3389_fnut_2020_584585
crossref_primary_10_1080_08820139_2023_2232403
crossref_primary_10_1172_JCI147276
crossref_primary_10_1016_j_scib_2024_12_039
crossref_primary_10_37748_2686_9039_2023_4_2_2
crossref_primary_10_1016_j_bbcan_2024_189160
crossref_primary_10_1186_s12943_025_02246_5
crossref_primary_10_18632_aging_204516
crossref_primary_10_3389_fnins_2023_1321176
crossref_primary_10_2217_cns_2020_0004
crossref_primary_10_1002_advs_202309554
crossref_primary_10_1002_ibra_12172
crossref_primary_10_3389_fimmu_2020_01869
crossref_primary_10_1158_0008_5472_CAN_21_4084
crossref_primary_10_1002_adbi_202200053
crossref_primary_10_1039_D4RA03638G
crossref_primary_10_3390_biomedicines11092555
crossref_primary_10_1016_j_colsurfa_2023_132576
crossref_primary_10_1007_s00204_024_03881_5
crossref_primary_10_3390_bios13010031
crossref_primary_10_1002_adfm_202401744
crossref_primary_10_62347_GHUM8504
crossref_primary_10_1186_s12967_025_06104_2
crossref_primary_10_3390_ijms232314695
crossref_primary_10_1007_s10717_024_00680_3
crossref_primary_10_1007_s12264_024_01238_7
crossref_primary_10_1016_j_biomaterials_2024_122852
crossref_primary_10_58502_DTT_23_0034
crossref_primary_10_1038_s41420_021_00450_y
crossref_primary_10_1186_s11658_022_00380_2
Cites_doi 10.1038/onc.2016.245
10.1038/nrclinonc.2011.123
10.1016/S1734-1140(13)71045-4
10.1016/j.semcancer.2007.12.004
10.1159/000100070
10.1016/j.imlet.2003.09.004
10.1186/s13046-018-0946-5
10.18632/oncotarget.15419
10.1002/cncr.26727
10.1016/j.jneuroim.2013.12.003
10.1038/onc.2014.253
10.1002/jcp.28214
10.1158/0008-5472.CAN-08-0202
10.1007/s00432-016-2278-1
10.2174/1566524014666141015152601
10.1002/ijc.31802
10.1016/j.peptides.2015.03.018
10.1186/s12885-018-4149-4
10.1007/s00280-016-3129-0
10.1053/j.gastro.2018.05.041
10.1038/nm1447
10.1016/j.ejphar.2011.05.077
10.1186/1471-2407-14-598
10.1158/2159-8290.CD-18-0046
10.1158/1078-0432.CCR-07-1778
10.1146/annurev.med.60.042307.110802
10.1111/j.1440-1746.2008.05687.x
10.1016/j.trecan.2017.11.008
10.1016/j.neuropharm.2016.02.011
10.1126/scitranslmed.aao4307
10.3109/10799893.2013.856918
10.1172/JCI40802
10.1001/jamaoncol.2017.2908
10.1080/09537104.2018.1478072
10.1016/j.cell.2016.05.042
10.1016/j.neuron.2015.01.026
10.1038/nrc3725
10.2147/OTT.S167422
10.1084/jem.20181169
10.1158/0008-5472.CAN-10-0522
10.1016/j.biochi.2018.06.016
10.1002/jcb.21802
10.1016/j.jneuroim.2019.02.007
10.1200/JCO.2012.43.9190
10.1021/cn500329r
10.1016/j.pupt.2017.12.001
10.1111/1440-1681.12787
10.1016/j.ccell.2016.11.005
10.1124/mol.116.107854
10.1016/j.pharep.2017.02.002
10.1016/j.phrs.2018.07.019
10.1073/pnas.1117792109
10.1093/carcin/bgz060
10.1158/0008-5472.CAN-07-2099
10.1016/j.canlet.2014.03.006
10.1016/S1470-2045(04)01431-7
10.1126/scitranslmed.3009569
10.1126/science.1236361
10.1126/science.aah5072
10.1016/S0753-3322(98)80019-X
10.1016/j.molcel.2019.04.017
10.1016/j.ccell.2017.02.005
10.1200/JCO.2010.33.5422
10.1016/j.canlet.2015.09.018
10.1038/s41586-019-1024-7
10.1053/j.gastro.2017.03.008
10.1074/jbc.M110.109579
10.1002/hep.23441
10.1016/j.npep.2015.10.005
10.1096/fj.201801429RR
10.1016/j.ccell.2017.11.007
10.1097/MED.0000000000000218
10.1371/journal.pone.0019246
10.1016/j.eururo.2013.01.007
10.1172/JCI33125
10.1007/s11481-017-9749-2
10.33549/physiolres.933671
10.1016/j.ajpath.2016.07.019
10.2174/138945011795528796
10.4103/1319-3767.187601
10.1111/jnc.13953
10.1186/s12943-018-0901-2
10.1182/blood-2006-01-028423
10.1038/ncomms10715
10.2174/1566524015666150114113411
10.1080/02841860801961265
10.1158/1078-0432.CCR-04-0059
10.2174/0929867324666170303121708
10.1016/j.jhep.2014.02.025
10.1038/nm.2173
10.1016/j.ejmech.2019.02.056
10.1200/JCO.2010.33.4441
10.1053/j.gastro.2016.08.040
10.1159/000492644
10.1016/j.lfs.2007.12.014
10.1016/j.ejca.2019.03.017
10.1158/0008-5472.CAN-16-2143
10.1080/10253890.2016.1203415
10.1136/gutjnl-2018-317479
10.1016/j.euroneuro.2015.05.008
10.1038/srep45686
10.1111/j.1476-5381.2010.00923.x
10.1007/s12272-018-1017-3
10.1016/j.ijcard.2014.09.178
10.1016/j.jphs.2017.05.002
10.1016/j.imlet.2018.07.006
10.1093/annonc/mdx264
10.1007/s11481-012-9395-7
10.1007/s00702-016-1661-z
10.1016/j.ccell.2016.05.002
10.1038/onc.2014.231
10.1084/jem.20172050
10.1189/jlb.5A1113-626RR
10.1093/rb/rbv013
10.1002/ijc.30443
10.1097/CAD.0b013e3283025b58
10.1593/neo.81630
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature Limited 2019
COPYRIGHT 2020 Nature Publishing Group
2019© The Author(s), under exclusive licence to Springer Nature Limited 2019
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature Limited 2019
– notice: COPYRIGHT 2020 Nature Publishing Group
– notice: 2019© The Author(s), under exclusive licence to Springer Nature Limited 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
DOI 10.1038/s41388-019-1006-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Proquest Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Research Library Prep
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1476-5594
EndPage 515
ExternalDocumentID A611469238
31527667
10_1038_s41388_019_1006_0
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 81871923, 81802890, and 81872242
  funderid: https://doi.org/10.13039/501100001809
GroupedDBID ---
-Q-
0R~
123
29N
2WC
36B
39C
4.4
406
53G
5RE
70F
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYZH
AAZLF
ABAKF
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACZOJ
ADBBV
ADFRT
ADHDB
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFSHS
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAP
EBLON
EBS
EE.
EIOEI
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
L7B
LGEZI
LK8
LOTEE
M0L
M1P
M2O
M7P
N9A
NADUK
NQJWS
NXXTH
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TSG
UKHRP
WH7
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEFQL
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
.55
.GJ
3O-
ABAWZ
ABDBF
ABEFU
ABRTQ
ACUHS
AFFNX
B0M
BAWUL
CAG
CGR
COF
CUY
CVF
EAD
EBC
EBD
ECM
EIF
EJD
EMB
EMK
EMOBN
EPL
FIZPM
NPM
OVD
PJZUB
PPXIY
PQGLB
RNS
SV3
TEORI
TR2
TUS
UDS
X7M
ZXP
~8M
AEIIB
PMFND
3V.
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
ID FETCH-LOGICAL-c439t-1ee5f970bb49035f2d68a3456522d3f3c4023f76bc3f7247de40c1a41c20657e3
IEDL.DBID 7X7
ISSN 0950-9232
1476-5594
IngestDate Fri Jul 11 08:09:24 EDT 2025
Fri Jul 25 08:58:28 EDT 2025
Tue Jun 17 20:52:30 EDT 2025
Tue Jun 10 20:42:57 EDT 2025
Mon Jul 21 05:49:52 EDT 2025
Thu Apr 24 23:10:29 EDT 2025
Tue Jul 01 02:45:49 EDT 2025
Fri Feb 21 02:38:35 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-1ee5f970bb49035f2d68a3456522d3f3c4023f76bc3f7247de40c1a41c20657e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-8965-223X
PMID 31527667
PQID 2343175755
PQPubID 36330
PageCount 13
ParticipantIDs proquest_miscellaneous_2292997769
proquest_journals_2343175755
gale_infotracmisc_A611469238
gale_infotracacademiconefile_A611469238
pubmed_primary_31527667
crossref_citationtrail_10_1038_s41388_019_1006_0
crossref_primary_10_1038_s41388_019_1006_0
springer_journals_10_1038_s41388_019_1006_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200116
PublicationDateYYYYMMDD 2020-01-16
PublicationDate_xml – month: 1
  year: 2020
  text: 20200116
  day: 16
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAbbrev Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Dimitrov, Lange, Gouttefangeas, Jensen, Szczepanski, Lehnnolz (CR21) 2019; 216
Palamiuc, Emerling (CR107) 2018; 215
Li, Tian, Wu (CR116) 2015; 2
Santala, Rannikko, Murtola (CR25) 2019; 144
Zila, Mokra, Kopincova, Kolomaznik, Javorka, Calkovska (CR99) 2017; 66
Lang, Bastian (CR62) 2007; 39
Liu, Zhang, Wang, Wu, Gong (CR72) 2019; 114
Thaker, Han, Kamat, Arevalo, Takahashi, Lu (CR12) 2006; 12
Kim, Myung, Park, Park (CR66) 2017; 140
Sarrouilhe, Mesnil (CR70) 2019; 161
Fujii, Mashimo, Moriwaki, Misawa, Ono, Horiguchi (CR98) 2017; 134
Sood, Armaiz-Pena, Halder, Nick, Stone, Hu (CR9) 2010; 120
Sarrouilhe, Clarhaut, Defamie, Mesnil (CR71) 2015; 15
Hayakawa, Sakitani, Konishi, Asfaha, Niikura, Tomita (CR96) 2017; 31
Roney, Park (CR34) 2018; 41
Renz, Tanaka, Sunagawa, Takahashi, Jiang, Macchini (CR94) 2018; 8
Chabbi-Achengli, Coudert, Callebert, Geoffroy, Cote, Collet (CR69) 2012; 109
Sarkar, Chakroborty, Chowdhury, Dasgupta, Basu (CR35) 2008; 14
Ribeiro, Custodio, Santos (CR103) 2017; 79
Wang, Ren, Wan, Prud'homme (CR64) 2019; 234
Briggs, Koivunen, Cao, Backus, Olenchock, Patel (CR105) 2016; 166
Grygier, Arteta, Kubera, Basta-Kaim, Budziszewska, Leskiewicz (CR81) 2013; 65
Galli, Naranjo, Van Ryn, Tilan, Trinh, Yang (CR117) 2016; 186
Magnon, Hall, Lin, Xue, Gerber, Freedland (CR10) 2013; 341
Arreola, Becerril-Villanueva, Cruz-Fuentes, Velasco-Velazquez, Garces-Alvarez, Hurtado-Alvarado (CR80) 2015; 2015
Hanoun, Maryanovich, Arnal-Estape, Frenette (CR2) 2015; 86
Lang, Drell, Niggemann, Zanker, Entschladen (CR61) 2003; 90
Kaczynska, Zajac, Wojciechowski, Kogut, Szereda-Przestaszewska (CR109) 2018; 48
Kim, Ly, Christodoulides, Nowell, Gunning, Sloan (CR20) 2019; 33
Rolland, Labreuche, Duhamel, Deheul, Gautier, Auffret (CR65) 2015; 25
Ouyang, Zhou, Yang, Cui, Xu, Yi (CR121) 2017; 44
Gumireddy, Li, Kossenkov, Sakurai, Yan, Li (CR53) 2016; 7
Czarnecka, Trinh, Lu, Kuan-Celarier, Galli, Hong (CR118) 2015; 34
Boilly, Faulkner, Jobling, Hondermarck (CR1) 2017; 31
Munoz, Covenas (CR114) 2016; 22
Jiang, Li, Dong, Yang, Liu, Yang (CR76) 2017; 153
De Giorgi, Grazzini, Benemei, Marchionni, Botteri, Pennacchioli (CR31) 2018; 4
Zhang, Li, Yao, Wei, Ning, Li (CR51) 2014; 348
Entschladen, Drell, Lang, Joseph, Zaenker (CR4) 2004; 5
Sloan, Priceman, Cox, Yu, Pimentel, Tangkanangnukul (CR22) 2010; 70
Shahzad, Arevalo, Armaiz-Pena, Lu, Stone, Moreno-Smith (CR18) 2010; 285
Pinoli, Marino, Cosentino (CR42) 2017; 12
Entschladen, Palm, Niggemann, Zaenker (CR3) 2008; 18
Kim, Toyofuku, Lynn, Chak, Uchida, Mizukami (CR68) 2010; 16
Farrelly, Thompson, Zhao, Lepack, Lyu, Bhanu (CR124) 2019; 567
Kanbara, Otsuki, Watanabe, Yokoe, Mori, Asahi (CR46) 2018; 18
Abdul, McCray, Hoosein (CR55) 2008; 47
Shimizu, Ibaragi, Eguchi, Kuwajima, Kodama, Nishioka (CR90) 2019; 54
Chakroborty, Chowdhury, Sarkar, Baral, Dasgupta, Basu (CR37) 2008; 118
Fujii, Horiguchi, Sunaga, Moriwaki, Misawa, Kasahara (CR101) 2014; 267
Anastas, Shi (CR123) 2019; 74
Schuller (CR56) 2018; 25
Moody, Nuche-Berenguer, Jensen (CR120) 2016; 23
Zhao, Hayakawa, Kodama, Muthupalani, Westphalen, Andersen (CR97) 2014; 6
Hsieh, Shen, Lin, Feng, Huang, Wang (CR85) 2016; 370
Powe, Entschladen (CR28) 2011; 8
Chakroborty, Sarkar, Mitra, Banerjee, Dasgupta, Basu (CR36) 2004; 10
Na, Qiao, Hao, Fan, Xiao, Shao (CR32) 2018; 11
Mammadova-Bach, Mauler, Braun, Duerschmied (CR77) 2018; 29
Soll, Jang, Riener, Moritz, Wild, Graf (CR75) 2010; 51
Cosentino, Fietta, Ferrari, Rasini, Bombelli, Carcano (CR44) 2007; 109
Xia, He, Zhu, Wang, Li, Zhang (CR60) 2017; 92
Shapovalov, Zettel, Spielman, Amico-Ruvio, Kelly, Sipe (CR82) 2014; 14
Tilan, Kitlinska (CR112) 2016; 55
Nocito, Dahm, Jochum, Jang, Georgiev, Bader (CR83) 2008; 68
Liu, Wu, Yu, Sung, Srivastava, Zhang (CR16) 2008; 105
Del Bello, Bonifazi, Giorgioni, Quaglia, Amantini, Morelli (CR73) 2019; 168
Takehara, Hosokawa, Eguchi, Ohigashi, Ishikawa, Nakamura (CR58) 2007; 67
Gautam, Banskota, Regmi, Ahn, Jeon, Jeong (CR74) 2016; 15
Moody, Moreno, Jensen (CR110) 2015; 72
Muma, Mi (CR79) 2015; 6
Yu, Xia, Tang, Xu, Wei, Chen (CR95) 2017; 7
Grytli, Fagerland, Fossa, Tasken (CR24) 2014; 65
Nasi, Ahmed, Rasini, Fenoglio, Marino, Filaci (CR45) 2019; 332
Blanchart, Fernando, Haring, Assaife-Lopes, Romanov, Andang (CR52) 2017; 36
Sarkar, Chakroborty, Basu (CR5) 2013; 8
Elisia, Cho, Hay, Li, Hofs, Lam (CR89) 2019; 40
Patane (CR93) 2014; 177
Li, Cho (CR92) 2011; 667
Nimmakayala, Seshacharyulu, Lakshmanan, Rachagani, Chugh, Karmakar (CR88) 2018; 155
Schaal, Bora-Singhal, Kumar, Chellappan (CR91) 2018; 17
Russo, Del Bufalo, Milic, Salinaro, Fini, Cesario (CR102) 2014; 14
Asada, Ebihara, Yamanda, Niu, Okazaki, Sora (CR78) 2009; 11
Zahalka, Arnal-Estape, Maryanovich, Nakahara, Cruz, Finley (CR13) 2017; 358
Nilsson, Sun, Diao, Tong, Liu, Li, Fan, Poteete, Lim, Howells, Haddad, Gomez, Tran, Pena, Sequist, Yang, Wang, Kim, Herbst, Lee, Hong, Wistuba, Hung, Sood, Heymach (CR7) 2017; 9
Maemura, Shiraishi, Sakagami, Kawakami, Inoue, Murano (CR50) 2009; 24
Gelb, Pshenichkin, Rodriguez, Hathaway, Grajkowska, DiRaddo (CR106) 2015; 34
Sung, Yang, Ju, Ahn (CR47) 2017; 49
Reijmen, Vannucci, De Couck, De Greve, Gidron (CR86) 2018; 202
Hujber, Horvath, Petovari, Krencz, Danko, Meszaros (CR49) 2018; 37
Krizanova, Babula, Pacak (CR6) 2016; 19
Levite (CR108) 2017; 124
Zhang, Du, Liu, He (CR48) 2014; 34
Sorensen, Ganz, Cole, Pedersen, Sorensen, Cronin-Fenton (CR27) 2013; 31
Le, Nowell, Kim-Fuchs, Botteri, Hiller, Ismail (CR8) 2016; 7
Coelho, Soares-Silva, Brandao, Marino, Cosentino, Ribeiro (CR15) 2017; 143
Wang, Huang, Chen (CR57) 2008; 82
Bergeret, Khrestchatisky, Tremblay, Bernard, Gregoire, Chany (CR63) 1998; 52
Munoz, Rosso, Covenas (CR113) 2011; 12
Yu, Wall, Wangari-Talbot, Chen (CR104) 2017; 115
Spera, Fresco, Fung, Dyck, Pituskin, Paterson (CR26) 2017; 28
Wu, Zhang, Tang, Gong, Zhou, Chen (CR43) 2015; 97
Inbar, Neeman, Avraham, Benish, Rosenne, Ben-Eliyahu (CR19) 2011; 6
Ondrovics, Hoelbl-Kovacic, Fux (CR119) 2017; 8
Schuller (CR59) 2008; 19
Berger, Gray, Roth (CR67) 2009; 60
Jansen, Below, Chang-Claude, Brenner, Hoffmeister (CR33) 2012; 118
Barron, Connolly, Sharp, Bennett, Visvanathan (CR29) 2011; 29
Covenas, Munoz (CR111) 2014; 29
Munoz, Rosso, Covenas (CR115) 2017; 69
Minami, Liu, Liu, Chen, Wan, Na (CR41) 2017; 7
Melhem-Bertrandt, Chavez-Macgregor, Lei, Brown, Lee, Meric-Bernstam (CR30) 2011; 29
Griffin, Faulkner, Jobling, Hondermarck (CR122) 2018; 135
Song, Gan, Wang, Meng, Li, Shen (CR23) 2017; 77
Li, Yang, Wang, Feng, Liu, Zhang (CR17) 2014; 60
Hondermarck, Jobling (CR14) 2018; 4
Renz, Takahashi, Tanaka, Macchini, Hayakawa, Dantes (CR11) 2018; 33
Jandaghi, Najafabadi, Bauer, Papadakis, Fassan, Hall (CR40) 2016; 151
Jiang, Zhu, Zhang, Li, Yang, Yan, Zhang, Yang, Dong, Dai, Hu, Li, Li, Wang, Yang, Zhang, Nie, Zhu, Zhang, Tian, Zhang, Cao, Tao, Huang, Jiang, Hua, Qian Luo, Gu, Sun, Hou, Zhang (CR54) 2019; 68
Dolma, Selvadurai, Lan, Lee, Kushida, Voisin (CR39) 2016; 29
Wu, Zhang, Deng, Xiao, Yuan, Zhang (CR38) 2018; 48
Kast (CR84) 2010; 161
Grando (CR100) 2014; 14
Wessler, Kirkpatrick (CR87) 2017; 142
HH Grytli (1006_CR24) 2014; 65
I Elisia (1006_CR89) 2019; 40
Y Chabbi-Achengli (1006_CR69) 2012; 109
M Munoz (1006_CR114) 2016; 22
HY Hsieh (1006_CR85) 2016; 370
XY Wu (1006_CR38) 2018; 48
CM Zhao (1006_CR97) 2014; 6
D Zhang (1006_CR51) 2014; 348
G Spera (1006_CR26) 2017; 28
K Maemura (1006_CR50) 2009; 24
K Kaczynska (1006_CR109) 2018; 48
M Coelho (1006_CR15) 2017; 143
D Sarrouilhe (1006_CR70) 2019; 161
R Covenas (1006_CR111) 2014; 29
LA Farrelly (1006_CR124) 2019; 567
C Sarkar (1006_CR35) 2008; 14
D Sarrouilhe (1006_CR71) 2015; 15
Y Liu (1006_CR72) 2019; 114
CM Schaal (1006_CR91) 2018; 17
L Palamiuc (1006_CR107) 2018; 215
S Xia (1006_CR60) 2017; 92
A Blanchart (1006_CR52) 2017; 36
L Jansen (1006_CR33) 2012; 118
EK Sloan (1006_CR22) 2010; 70
RK Nimmakayala (1006_CR88) 2018; 155
Q Ouyang (1006_CR121) 2017; 44
X Liu (1006_CR16) 2008; 105
NA Muma (1006_CR79) 2015; 6
TH Kim (1006_CR20) 2019; 33
B Boilly (1006_CR1) 2017; 31
F Del Bello (1006_CR73) 2019; 168
LJ Yu (1006_CR104) 2017; 115
O Krizanova (1006_CR6) 2016; 19
MM Shahzad (1006_CR18) 2010; 285
R Shimizu (1006_CR90) 2019; 54
EE Santala (1006_CR25) 2019; 144
JN Anastas (1006_CR123) 2019; 74
T Wang (1006_CR57) 2008; 82
H Hondermarck (1006_CR14) 2018; 4
H Yu (1006_CR95) 2017; 7
Z Na (1006_CR32) 2018; 11
M Bergeret (1006_CR63) 1998; 52
J Gautam (1006_CR74) 2016; 15
TW Moody (1006_CR110) 2015; 72
K Minami (1006_CR41) 2017; 7
HB Kim (1006_CR66) 2017; 140
AH Zahalka (1006_CR13) 2017; 358
F Entschladen (1006_CR3) 2008; 18
T Gelb (1006_CR106) 2015; 34
M Munoz (1006_CR113) 2011; 12
ZJ Li (1006_CR92) 2011; 667
M Cosentino (1006_CR44) 2007; 109
M Munoz (1006_CR115) 2017; 69
M Berger (1006_CR67) 2009; 60
F Entschladen (1006_CR4) 2004; 5
P Russo (1006_CR102) 2014; 14
G Nasi (1006_CR45) 2019; 332
SH Jiang (1006_CR76) 2017; 153
B Grygier (1006_CR81) 2013; 65
M Ondrovics (1006_CR119) 2017; 8
TW Moody (1006_CR120) 2016; 23
S Galli (1006_CR117) 2016; 186
K Lang (1006_CR61) 2003; 90
HY Sung (1006_CR47) 2017; 49
HM Schuller (1006_CR56) 2018; 25
T Fujii (1006_CR98) 2017; 134
K Gumireddy (1006_CR53) 2016; 7
AK Sood (1006_CR9) 2010; 120
S Patane (1006_CR93) 2014; 177
Y Song (1006_CR23) 2017; 77
A Nocito (1006_CR83) 2008; 68
C Magnon (1006_CR10) 2013; 341
Qinghua Wang (1006_CR64) 2019; 234
K Kanbara (1006_CR46) 2018; 18
S Inbar (1006_CR19) 2011; 6
R Arreola (1006_CR80) 2015; 2015
J Wu (1006_CR43) 2015; 97
M Hanoun (1006_CR2) 2015; 86
TI Barron (1006_CR29) 2011; 29
D Chakroborty (1006_CR36) 2004; 10
M Asada (1006_CR78) 2009; 11
C Soll (1006_CR75) 2010; 51
X Zhang (1006_CR48) 2014; 34
M Levite (1006_CR108) 2017; 124
P Jandaghi (1006_CR40) 2016; 151
Y Shapovalov (1006_CR82) 2014; 14
DG Powe (1006_CR28) 2011; 8
BW Renz (1006_CR94) 2018; 8
Y Hayakawa (1006_CR96) 2017; 31
PH Thaker (1006_CR12) 2006; 12
M Abdul (1006_CR55) 2008; 47
K Lang (1006_CR62) 2007; 39
J Tilan (1006_CR112) 2016; 55
Monique B. Nilsson (1006_CR7) 2017; 9
M Czarnecka (1006_CR118) 2015; 34
M Pinoli (1006_CR42) 2017; 12
B Rolland (1006_CR65) 2015; 25
S Dolma (1006_CR39) 2016; 29
N Griffin (1006_CR122) 2018; 135
Shu-Heng Jiang (1006_CR54) 2019; 68
H Kim (1006_CR68) 2010; 16
KJ Briggs (1006_CR105) 2016; 166
A Takehara (1006_CR58) 2007; 67
BW Renz (1006_CR11) 2018; 33
CP Le (1006_CR8) 2016; 7
Z Hujber (1006_CR49) 2018; 37
D Chakroborty (1006_CR37) 2008; 118
J Li (1006_CR17) 2014; 60
V De Giorgi (1006_CR31) 2018; 4
I Zila (1006_CR99) 2017; 66
E Reijmen (1006_CR86) 2018; 202
E Mammadova-Bach (1006_CR77) 2018; 29
MSI Roney (1006_CR34) 2018; 41
HM Schuller (1006_CR59) 2008; 19
RE Kast (1006_CR84) 2010; 161
MP Ribeiro (1006_CR103) 2017; 79
T Fujii (1006_CR101) 2014; 267
C Sarkar (1006_CR5) 2013; 8
S Dimitrov (1006_CR21) 2019; 216
IK Wessler (1006_CR87) 2017; 142
GV Sorensen (1006_CR27) 2013; 31
A Melhem-Bertrandt (1006_CR30) 2011; 29
J Li (1006_CR116) 2015; 2
SA Grando (1006_CR100) 2014; 14
References_xml – volume: 25
  start-page: 2566
  year: 2018
  end-page: 75
  ident: CR56
  article-title: Regulatory role of G protein-coupled receptors in pancreatic cancer development and progression
  publication-title: Curr Med Chem
– volume: 90
  start-page: 165
  year: 2003
  end-page: 72
  ident: CR61
  article-title: Neurotransmitters regulate the migration and cytotoxicity in natural killer cells
  publication-title: Immunol Lett
– volume: 114
  start-page: 8
  year: 2019
  end-page: 24
  ident: CR72
  article-title: 5-Hydroxytryptamine1a receptors on tumour cells induce immune evasion in lung adenocarcinoma patients with depression via autophagy/pSTAT3
  publication-title: Eur J Cancer
– volume: 144
  start-page: 440
  year: 2019
  end-page: 7
  ident: CR25
  article-title: Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study
  publication-title: Int J Cancer
– volume: 15
  start-page: 62
  year: 2015
  end-page: 77
  ident: CR71
  article-title: Serotonin and cancer: what is the link?
  publication-title: Curr Mol Med
– volume: 11
  start-page: 408
  year: 2009
  end-page: 17
  ident: CR78
  article-title: Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation
  publication-title: Neoplasia
– volume: 115
  start-page: 193
  year: 2017
  end-page: 202
  ident: CR104
  article-title: Metabotropic glutamate receptors in cancer
  publication-title: Neuropharmacology
– volume: 66
  start-page: S139
  issue: Suppl 2
  year: 2017
  end-page: S45
  ident: CR99
  article-title: Vagal-immune interactions involved in cholinergic anti-inflammatory pathway
  publication-title: Physiol Res
– volume: 134
  start-page: 1
  year: 2017
  end-page: 21
  ident: CR98
  article-title: Physiological functions of the cholinergic system in immune cells
  publication-title: J Pharm Sci
– volume: 14
  start-page: 2502
  year: 2008
  end-page: 10
  ident: CR35
  article-title: Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models
  publication-title: Clin Cancer Res
– volume: 31
  start-page: 342
  year: 2017
  end-page: 54
  ident: CR1
  article-title: Nerve dependence: from regeneration to cancer
  publication-title: Cancer Cell
– volume: 6
  year: 2011
  ident: CR19
  article-title: Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity
  publication-title: PLoS ONE
– volume: 29
  start-page: 2645
  year: 2011
  end-page: 52
  ident: CR30
  article-title: Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer
  publication-title: J Clin Oncol
– volume: 7
  year: 2016
  ident: CR8
  article-title: Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination
  publication-title: Nat Commun
– volume: 109
  start-page: 632
  year: 2007
  end-page: 42
  ident: CR44
  article-title: Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
  publication-title: Blood
– volume: 36
  start-page: 777
  year: 2017
  end-page: 86
  ident: CR52
  article-title: Endogenous GABAA receptor activity suppresses glioma growth
  publication-title: Oncogene
– volume: 19
  start-page: 655
  year: 2008
  end-page: 71
  ident: CR59
  article-title: Neurotransmission and cancer: implications for prevention and therapy
  publication-title: Anticancer drugs
– volume: 135
  start-page: 12
  year: 2018
  end-page: 7
  ident: CR122
  article-title: Targeting neurotrophin signaling in cancer: the renaissance
  publication-title: Pharm Res
– volume: 332
  start-page: 233
  year: 2019
  end-page: 41
  ident: CR45
  article-title: Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors
  publication-title: J Neuroimmunol
– volume: 118
  start-page: 1380
  year: 2008
  end-page: 9
  ident: CR37
  article-title: Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization
  publication-title: J Clin Investig
– volume: 143
  start-page: 275
  year: 2017
  end-page: 91
  ident: CR15
  article-title: Beta-adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives
  publication-title: J Cancer Res Clin Oncol
– volume: 39
  start-page: 99
  year: 2007
  end-page: 121
  ident: CR62
  article-title: Neurotransmitter effects on tumor cells and leukocytes
  publication-title: Prog Exp Tumor Res
– volume: 124
  start-page: 775
  year: 2017
  end-page: 98
  ident: CR108
  article-title: Glutamate, T cells and multiple sclerosis
  publication-title: J Neural Transm
– volume: 60
  start-page: 1225
  year: 2014
  end-page: 34
  ident: CR17
  article-title: Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling
  publication-title: J Hepatol
– volume: 14
  year: 2014
  ident: CR82
  article-title: Fluoxetine modulates breast cancer metastasis to the brain in a murine model
  publication-title: BMC Cancer
– volume: 34
  start-page: 431
  year: 2014
  end-page: 9
  ident: CR48
  article-title: Gamma-aminobutyric acid receptors affect the progression and migration of tumor cells
  publication-title: J Recept Signal Transduct Res
– volume: 120
  start-page: 1515
  year: 2010
  end-page: 23
  ident: CR9
  article-title: Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
  publication-title: J Clin Investig
– volume: 47
  start-page: 1546
  year: 2008
  end-page: 50
  ident: CR55
  article-title: Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer
  publication-title: Acta Oncol
– volume: 86
  start-page: 360
  year: 2015
  end-page: 73
  ident: CR2
  article-title: Neural regulation of hematopoiesis, inflammation, and cancer
  publication-title: Neuron
– volume: 40
  start-page: 448
  year: 2019
  end-page: 60
  ident: CR89
  article-title: The effect of diet and exercise on tobacco carcinogen-induced lung cancer
  publication-title: Carcinogenesis
– volume: 22
  start-page: 260
  year: 2016
  end-page: 8
  ident: CR114
  article-title: Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: a new approach
  publication-title: Saudi J Gastroenterol
– volume: 348
  start-page: 100
  year: 2014
  end-page: 8
  ident: CR51
  article-title: GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation
  publication-title: Cancer Lett
– volume: 52
  start-page: 214
  year: 1998
  end-page: 9
  ident: CR63
  article-title: GABA modulates cytotoxicity of immunocompetent cells expressing GABAA receptor subunits
  publication-title: Biomed Pharmacother
– volume: 4
  year: 2018
  ident: CR31
  article-title: Propranolol for off-label treatment of patients with melanoma: results from a cohort study
  publication-title: JAMA Oncol
– volume: 4
  start-page: 93
  year: 2018
  end-page: 4
  ident: CR14
  article-title: The sympathetic nervous system drives tumor angiogenesis
  publication-title: Trends Cancer
– volume: 41
  start-page: 384
  year: 2018
  end-page: 408
  ident: CR34
  article-title: Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells
  publication-title: Arch Pharm Res
– volume: 177
  start-page: 646
  year: 2014
  end-page: 9
  ident: CR93
  article-title: M3 muscarinic acetylcholine receptor in cardiology and oncology
  publication-title: Int J Cardiol
– volume: 77
  start-page: 1611
  year: 2017
  end-page: 22
  ident: CR23
  article-title: Enriching the housing environment for mice enhances their NK cell antitumor immunity via sympathetic nerve-dependent regulation of NKG2D and CCR5
  publication-title: Cancer Res
– volume: 70
  start-page: 7042
  year: 2010
  end-page: 52
  ident: CR22
  article-title: The sympathetic nervous system induces a metastatic switch in primary breast cancer
  publication-title: Cancer Res
– volume: 37
  start-page: 271
  year: 2018
  ident: CR49
  article-title: GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
  publication-title: J Exp Clin cancer Res
– volume: 92
  start-page: 265
  year: 2017
  end-page: 77
  ident: CR60
  article-title: GABABR-Induced EGFR transactivation promotes migration of human prostate cancer cells
  publication-title: Mol Pharm
– volume: 2015
  start-page: 354957
  year: 2015
  ident: CR80
  article-title: Immunomodulatory effects mediated by serotonin
  publication-title: J Immunol Res
– volume: 12
  start-page: 602
  year: 2017
  end-page: 23
  ident: CR42
  article-title: Dopaminergic regulation of innate immunity: a review
  publication-title: J NeuroImmune Pharmacol
– volume: 29
  start-page: 881
  year: 2014
  end-page: 90
  ident: CR111
  article-title: Cancer progression and substance P
  publication-title: Histol Histopathol
– volume: 2
  start-page: 215
  year: 2015
  end-page: 9
  ident: CR116
  article-title: Neuropeptide Y receptors: a promising target for cancer imaging and therapy
  publication-title: Regen Biomater
– volume: 23
  start-page: 38
  year: 2016
  end-page: 47
  ident: CR120
  article-title: Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer
  publication-title: Curr Opin Endocrinol Diabetes Obes
– volume: 34
  start-page: 3131
  year: 2015
  end-page: 43
  ident: CR118
  article-title: Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
  publication-title: Oncogene
– volume: 79
  start-page: 219
  year: 2017
  end-page: 25
  ident: CR103
  article-title: Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box?
  publication-title: Cancer Chemother Pharm
– volume: 29
  start-page: 541
  year: 2018
  end-page: 8
  ident: CR77
  article-title: Autocrine and paracrine regulatory functions of platelet serotonin
  publication-title: Platelets
– volume: 19
  start-page: 419
  year: 2016
  end-page: 28
  ident: CR6
  article-title: Stress, catecholaminergic system and cancer
  publication-title: Stress
– volume: 11
  start-page: 4913
  year: 2018
  end-page: 44
  ident: CR32
  article-title: The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients
  publication-title: Onco Targets Ther
– volume: 140
  start-page: 513
  year: 2017
  end-page: 25
  ident: CR66
  article-title: Use of benzodiazepine and risk of cancer: a meta-analysis of observational studies
  publication-title: Int J Cancer
– volume: 48
  start-page: 217
  year: 2018
  end-page: 24
  ident: CR109
  article-title: Neuropeptides and breathing in health and disease
  publication-title: Pulm Pharm Ther
– volume: 358
  start-page: 321
  year: 2017
  end-page: 6
  ident: CR13
  article-title: Adrenergic nerves activate an angio-metabolic switch in prostate cancer
  publication-title: Science
– volume: 168
  start-page: 461
  year: 2019
  end-page: 73
  ident: CR73
  article-title: Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells
  publication-title: Eur J Med Chem
– volume: 166
  start-page: 126
  year: 2016
  end-page: 39
  ident: CR105
  article-title: Paracrine Induction of HIF by glutamate in breast cancer: EglN1 senses cysteine
  publication-title: Cell
– volume: 6
  start-page: 250ra115
  year: 2014
  ident: CR97
  article-title: Denervation suppresses gastric tumorigenesis
  publication-title: Sci Transl Med
– volume: 9
  start-page: eaao4307
  issue: 415
  year: 2017
  ident: CR7
  article-title: Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers
  publication-title: Science Translational Medicine
– volume: 667
  start-page: 17
  year: 2011
  end-page: 22
  ident: CR92
  article-title: Neurotransmitters, more than meets the eye–neurotransmitters and their perspectives in cancer development and therapy
  publication-title: Eur J Pharm
– volume: 24
  start-page: 688
  year: 2009
  end-page: 96
  ident: CR50
  article-title: Proliferative effects of gamma-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1/2 activation
  publication-title: J Gastroenterol Hepatol
– volume: 34
  start-page: 2711
  year: 2015
  end-page: 20
  ident: CR106
  article-title: Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas
  publication-title: Oncogene
– volume: 370
  start-page: 56
  year: 2016
  end-page: 65
  ident: CR85
  article-title: Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3beta to suppress mTOR and beta-catenin signaling pathways
  publication-title: Cancer Lett
– volume: 33
  start-page: 3997
  year: 2019
  end-page: 4006
  ident: CR20
  article-title: Stress hormone signaling through beta-adrenergic receptors regulates macrophage mechanotype and function
  publication-title: FASEB J
– volume: 267
  start-page: 43
  year: 2014
  end-page: 9
  ident: CR101
  article-title: SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity
  publication-title: J Neuroimmunol
– volume: 14
  start-page: 1126
  year: 2014
  end-page: 38
  ident: CR102
  article-title: Cholinergic receptors as target for cancer therapy in a systems medicine perspective
  publication-title: Curr Mol Med
– volume: 18
  start-page: 171
  year: 2008
  end-page: 5
  ident: CR3
  article-title: The cancer’s nervous tooth: considering the neuronal crosstalk within tumors
  publication-title: Semin Cancer Biol
– volume: 51
  start-page: 1244
  year: 2010
  end-page: 54
  ident: CR75
  article-title: Serotonin promotes tumor growth in human hepatocellular cancer
  publication-title: Hepatology
– volume: 216
  start-page: 517
  year: 2019
  end-page: 26
  ident: CR21
  article-title: Galphas-coupled receptor signaling and sleep regulate integrin activation of human antigen-specific T cells
  publication-title: J Exp Med
– volume: 31
  start-page: 2265
  year: 2013
  end-page: 72
  ident: CR27
  article-title: Use of beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study
  publication-title: J Clin Oncol
– volume: 109
  start-page: 2567
  year: 2012
  end-page: 72
  ident: CR69
  article-title: Decreased osteoclastogenesis in serotonin-deficient mice
  publication-title: Proc Natl Acad Sci USA
– volume: 341
  start-page: 1236361
  year: 2013
  ident: CR10
  article-title: Autonomic nerve development contributes to prostate cancer progression
  publication-title: Science
– volume: 285
  start-page: 35462
  year: 2010
  end-page: 70
  ident: CR18
  article-title: Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis
  publication-title: J Biol Chem
– volume: 8
  start-page: 511
  year: 2011
  end-page: 2
  ident: CR28
  article-title: Targeted therapies: using beta-blockers to inhibit breast cancer progression
  publication-title: Nat Rev Clin Oncol
– volume: 29
  start-page: 2635
  year: 2011
  end-page: 44
  ident: CR29
  article-title: Beta blockers and breast cancer mortality: a population-based study
  publication-title: J Clin Oncol
– volume: 28
  start-page: 1836
  year: 2017
  end-page: 41
  ident: CR26
  article-title: Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study
  publication-title: Ann Oncol
– volume: 68
  start-page: 5152
  year: 2008
  end-page: 8
  ident: CR83
  article-title: Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts
  publication-title: Cancer Res
– volume: 5
  start-page: 254
  year: 2004
  end-page: 8
  ident: CR4
  article-title: Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters
  publication-title: Lancet Oncol
– volume: 10
  start-page: 4349
  year: 2004
  end-page: 56
  ident: CR36
  article-title: Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis
  publication-title: Clin Cancer Res
– volume: 69
  start-page: 696
  year: 2017
  end-page: 701
  ident: CR115
  article-title: The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines
  publication-title: Pharmacol Rep
– volume: 97
  start-page: 191
  year: 2015
  end-page: 200
  ident: CR43
  article-title: Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity
  publication-title: J Leukoc Biol
– volume: 161
  start-page: 481
  year: 2010
  end-page: 7
  ident: CR84
  article-title: Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines
  publication-title: Br J Pharm
– volume: 18
  year: 2018
  ident: CR46
  article-title: GABAB receptor regulates proliferation in the high-grade chondrosarcoma cell line OUMS-27 via apoptotic pathways
  publication-title: BMC Cancer
– volume: 8
  start-page: 7
  year: 2013
  end-page: 14
  ident: CR5
  article-title: Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines
  publication-title: J NeuroImmune Pharmacol
– volume: 161
  start-page: 46
  year: 2019
  end-page: 50
  ident: CR70
  article-title: Serotonin and human cancer: a critical view
  publication-title: Biochimie
– volume: 68
  start-page: 1994
  issue: 11
  year: 2019
  end-page: 2006
  ident: CR54
  article-title: GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner
  publication-title: Gut
– volume: 118
  start-page: 3911
  year: 2012
  end-page: 9
  ident: CR33
  article-title: Beta blocker use and colorectal cancer risk: population-based case-control study
  publication-title: Cancer
– volume: 105
  start-page: 53
  year: 2008
  end-page: 60
  ident: CR16
  article-title: Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway
  publication-title: J Cell Biochem
– volume: 65
  start-page: 635
  year: 2014
  end-page: 41
  ident: CR24
  article-title: Association between use of beta-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease
  publication-title: Eur Urol
– volume: 8
  start-page: 1458
  year: 2018
  end-page: 73
  ident: CR94
  article-title: Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness
  publication-title: Cancer Discov
– volume: 67
  start-page: 9704
  year: 2007
  end-page: 12
  ident: CR58
  article-title: Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit
  publication-title: Cancer Res
– volume: 12
  start-page: 909
  year: 2011
  end-page: 21
  ident: CR113
  article-title: The NK-1 receptor: a new target in cancer therapy
  publication-title: Curr Drug Targets
– volume: 15
  year: 2016
  ident: CR74
  article-title: Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling
  publication-title: Mol Cancer
– volume: 44
  start-page: 841
  year: 2017
  end-page: 6
  ident: CR121
  article-title: Oncogenic role of neurotensin and neurotensin receptors in various cancers
  publication-title: Clin Exp Pharmacol Physiol
– volume: 55
  start-page: 55
  year: 2016
  end-page: 66
  ident: CR112
  article-title: Neuropeptide Y (NPY) in tumor growth and progression: lessons learned from pediatric oncology
  publication-title: Neuropeptides
– volume: 12
  start-page: 939
  year: 2006
  end-page: 44
  ident: CR12
  article-title: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
  publication-title: Nat Med
– volume: 8
  start-page: 25783
  year: 2017
  end-page: 96
  ident: CR119
  article-title: Opioids: modulators of angiogenesis in wound healing and cancer
  publication-title: Oncotarget
– volume: 48
  start-page: 2258
  year: 2018
  end-page: 72
  ident: CR38
  article-title: Overexpressed D2 dopamine receptor inhibits non-small cell lung cancer progression through inhibiting NF-kappaB signaling pathway
  publication-title: Cell Physiol Biochem
– volume: 142
  start-page: 144
  issue: Suppl 2
  year: 2017
  end-page: 50
  ident: CR87
  article-title: Non-neuronal acetylcholine involved in reproduction in mammals and honeybees
  publication-title: J Neurochem
– volume: 17
  year: 2018
  ident: CR91
  article-title: Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer
  publication-title: Mol Cancer
– volume: 29
  start-page: 859
  year: 2016
  end-page: 73
  ident: CR39
  article-title: Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells
  publication-title: Cancer Cell
– volume: 14
  start-page: 419
  year: 2014
  end-page: 29
  ident: CR100
  article-title: Connections of nicotine to cancer
  publication-title: Nat Rev Cancer
– volume: 25
  start-page: 1631
  year: 2015
  end-page: 6
  ident: CR65
  article-title: Baclofen for alcohol dependence: relationships between baclofen and alcohol dosing and the occurrence of major sedation
  publication-title: Eur Neuropsychopharmacol
– volume: 7
  year: 2016
  ident: CR53
  article-title: The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis
  publication-title: Nat Commun
– volume: 567
  start-page: 535
  year: 2019
  end-page: 9
  ident: CR124
  article-title: Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3
  publication-title: Nature
– volume: 31
  start-page: 21
  year: 2017
  end-page: 34
  ident: CR96
  article-title: Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling
  publication-title: Cancer Cell
– volume: 33
  start-page: 75
  year: 2018
  end-page: 90 e7
  ident: CR11
  article-title: Beta2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer
  publication-title: Cancer Cell
– volume: 6
  start-page: 961
  year: 2015
  end-page: 9
  ident: CR79
  article-title: Serotonylation and transamidation of other monoamines
  publication-title: ACS Chem Neurosci
– volume: 202
  start-page: 38
  year: 2018
  end-page: 43
  ident: CR86
  article-title: Therapeutic potential of the vagus nerve in cancer
  publication-title: Immunol Lett
– volume: 16
  start-page: 804
  year: 2010
  end-page: 8
  ident: CR68
  article-title: Serotonin regulates pancreatic beta cell mass during pregnancy
  publication-title: Nat Med
– volume: 7
  year: 2017
  ident: CR41
  article-title: Inhibitory effects of dopamine receptor D1 agonist on mammary tumor and bone metastasis
  publication-title: Sci Rep
– volume: 72
  start-page: 106
  year: 2015
  end-page: 11
  ident: CR110
  article-title: Neuropeptides as lung cancer growth factors
  publication-title: Peptides
– volume: 155
  start-page: 892
  year: 2018
  end-page: 908 e6.
  ident: CR88
  article-title: Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1
  publication-title: Gastroenterology
– volume: 74
  start-page: 418
  year: 2019
  end-page: 20
  ident: CR123
  article-title: Histone serotonylation: can the brain have “Happy” chromatin?
  publication-title: Mol Cell
– volume: 60
  start-page: 355
  year: 2009
  end-page: 66
  ident: CR67
  article-title: The expanded biology of serotonin
  publication-title: Annu Rev Med
– volume: 186
  start-page: 3040
  year: 2016
  end-page: 53
  ident: CR117
  article-title: Neuropeptide Y as a biomarker and therapeutic target for neuroblastoma
  publication-title: Am J Pathol
– volume: 151
  start-page: 1218
  year: 2016
  end-page: 31
  ident: CR40
  article-title: Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice
  publication-title: Gastroenterology
– volume: 82
  start-page: 536
  year: 2008
  end-page: 41
  ident: CR57
  article-title: Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo
  publication-title: Life Sci
– volume: 54
  start-page: 283
  year: 2019
  end-page: 94
  ident: CR90
  article-title: Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma
  publication-title: Int J Oncol
– volume: 215
  start-page: 17
  year: 2018
  end-page: 9
  ident: CR107
  article-title: PSMA brings new flavors to PI3K signaling: a role for glutamate in prostate cancer
  publication-title: J Exp Med
– volume: 234
  start-page: 14432
  issue: 9
  year: 2019
  end-page: 14444
  ident: CR64
  article-title: GABAergic regulation of pancreatic islet cells: Physiology and antidiabetic effects
  publication-title: Journal of Cellular Physiology
– volume: 153
  start-page: 277
  year: 2017
  end-page: 91 e19
  ident: CR76
  article-title: Increased serotonin signaling contributes to the Warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice
  publication-title: Gastroenterology
– volume: 65
  start-page: 672
  year: 2013
  end-page: 81
  ident: CR81
  article-title: Inhibitory effect of antidepressants on B16F10 melanoma tumor growth
  publication-title: Pharmacol Rep
– volume: 7
  year: 2017
  ident: CR95
  article-title: Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation
  publication-title: Sci Rep
– volume: 49
  year: 2017
  ident: CR47
  article-title: Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer
  publication-title: Exp Mol Med
– volume: 15
  year: 2016
  ident: 1006_CR74
  publication-title: Mol Cancer
– volume: 36
  start-page: 777
  year: 2017
  ident: 1006_CR52
  publication-title: Oncogene
  doi: 10.1038/onc.2016.245
– volume: 8
  start-page: 511
  year: 2011
  ident: 1006_CR28
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2011.123
– volume: 65
  start-page: 672
  year: 2013
  ident: 1006_CR81
  publication-title: Pharmacol Rep
  doi: 10.1016/S1734-1140(13)71045-4
– volume: 18
  start-page: 171
  year: 2008
  ident: 1006_CR3
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2007.12.004
– volume: 39
  start-page: 99
  year: 2007
  ident: 1006_CR62
  publication-title: Prog Exp Tumor Res
  doi: 10.1159/000100070
– volume: 90
  start-page: 165
  year: 2003
  ident: 1006_CR61
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2003.09.004
– volume: 37
  start-page: 271
  year: 2018
  ident: 1006_CR49
  publication-title: J Exp Clin cancer Res
  doi: 10.1186/s13046-018-0946-5
– volume: 8
  start-page: 25783
  year: 2017
  ident: 1006_CR119
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.15419
– volume: 118
  start-page: 3911
  year: 2012
  ident: 1006_CR33
  publication-title: Cancer
  doi: 10.1002/cncr.26727
– volume: 267
  start-page: 43
  year: 2014
  ident: 1006_CR101
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2013.12.003
– volume: 34
  start-page: 3131
  year: 2015
  ident: 1006_CR118
  publication-title: Oncogene
  doi: 10.1038/onc.2014.253
– volume: 234
  start-page: 14432
  issue: 9
  year: 2019
  ident: 1006_CR64
  publication-title: Journal of Cellular Physiology
  doi: 10.1002/jcp.28214
– volume: 68
  start-page: 5152
  year: 2008
  ident: 1006_CR83
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-0202
– volume: 143
  start-page: 275
  year: 2017
  ident: 1006_CR15
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-016-2278-1
– volume: 14
  start-page: 1126
  year: 2014
  ident: 1006_CR102
  publication-title: Curr Mol Med
  doi: 10.2174/1566524014666141015152601
– volume: 144
  start-page: 440
  year: 2019
  ident: 1006_CR25
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31802
– volume: 72
  start-page: 106
  year: 2015
  ident: 1006_CR110
  publication-title: Peptides
  doi: 10.1016/j.peptides.2015.03.018
– volume: 18
  year: 2018
  ident: 1006_CR46
  publication-title: BMC Cancer
  doi: 10.1186/s12885-018-4149-4
– volume: 79
  start-page: 219
  year: 2017
  ident: 1006_CR103
  publication-title: Cancer Chemother Pharm
  doi: 10.1007/s00280-016-3129-0
– volume: 155
  start-page: 892
  year: 2018
  ident: 1006_CR88
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2018.05.041
– volume: 12
  start-page: 939
  year: 2006
  ident: 1006_CR12
  publication-title: Nat Med
  doi: 10.1038/nm1447
– volume: 667
  start-page: 17
  year: 2011
  ident: 1006_CR92
  publication-title: Eur J Pharm
  doi: 10.1016/j.ejphar.2011.05.077
– volume: 14
  year: 2014
  ident: 1006_CR82
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-598
– volume: 8
  start-page: 1458
  year: 2018
  ident: 1006_CR94
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-18-0046
– volume: 14
  start-page: 2502
  year: 2008
  ident: 1006_CR35
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-1778
– volume: 60
  start-page: 355
  year: 2009
  ident: 1006_CR67
  publication-title: Annu Rev Med
  doi: 10.1146/annurev.med.60.042307.110802
– volume: 24
  start-page: 688
  year: 2009
  ident: 1006_CR50
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2008.05687.x
– volume: 4
  start-page: 93
  year: 2018
  ident: 1006_CR14
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2017.11.008
– volume: 115
  start-page: 193
  year: 2017
  ident: 1006_CR104
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2016.02.011
– volume: 9
  start-page: eaao4307
  issue: 415
  year: 2017
  ident: 1006_CR7
  publication-title: Science Translational Medicine
  doi: 10.1126/scitranslmed.aao4307
– volume: 34
  start-page: 431
  year: 2014
  ident: 1006_CR48
  publication-title: J Recept Signal Transduct Res
  doi: 10.3109/10799893.2013.856918
– volume: 120
  start-page: 1515
  year: 2010
  ident: 1006_CR9
  publication-title: J Clin Investig
  doi: 10.1172/JCI40802
– volume: 7
  year: 2017
  ident: 1006_CR95
  publication-title: Sci Rep
– volume: 4
  year: 2018
  ident: 1006_CR31
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2017.2908
– volume: 29
  start-page: 541
  year: 2018
  ident: 1006_CR77
  publication-title: Platelets
  doi: 10.1080/09537104.2018.1478072
– volume: 166
  start-page: 126
  year: 2016
  ident: 1006_CR105
  publication-title: Cell
  doi: 10.1016/j.cell.2016.05.042
– volume: 86
  start-page: 360
  year: 2015
  ident: 1006_CR2
  publication-title: Neuron
  doi: 10.1016/j.neuron.2015.01.026
– volume: 49
  year: 2017
  ident: 1006_CR47
  publication-title: Exp Mol Med
– volume: 14
  start-page: 419
  year: 2014
  ident: 1006_CR100
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3725
– volume: 11
  start-page: 4913
  year: 2018
  ident: 1006_CR32
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S167422
– volume: 216
  start-page: 517
  year: 2019
  ident: 1006_CR21
  publication-title: J Exp Med
  doi: 10.1084/jem.20181169
– volume: 70
  start-page: 7042
  year: 2010
  ident: 1006_CR22
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-0522
– volume: 161
  start-page: 46
  year: 2019
  ident: 1006_CR70
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2018.06.016
– volume: 105
  start-page: 53
  year: 2008
  ident: 1006_CR16
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.21802
– volume: 332
  start-page: 233
  year: 2019
  ident: 1006_CR45
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2019.02.007
– volume: 31
  start-page: 2265
  year: 2013
  ident: 1006_CR27
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.43.9190
– volume: 6
  start-page: 961
  year: 2015
  ident: 1006_CR79
  publication-title: ACS Chem Neurosci
  doi: 10.1021/cn500329r
– volume: 48
  start-page: 217
  year: 2018
  ident: 1006_CR109
  publication-title: Pulm Pharm Ther
  doi: 10.1016/j.pupt.2017.12.001
– volume: 44
  start-page: 841
  year: 2017
  ident: 1006_CR121
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1111/1440-1681.12787
– volume: 31
  start-page: 21
  year: 2017
  ident: 1006_CR96
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.11.005
– volume: 92
  start-page: 265
  year: 2017
  ident: 1006_CR60
  publication-title: Mol Pharm
  doi: 10.1124/mol.116.107854
– volume: 69
  start-page: 696
  year: 2017
  ident: 1006_CR115
  publication-title: Pharmacol Rep
  doi: 10.1016/j.pharep.2017.02.002
– volume: 135
  start-page: 12
  year: 2018
  ident: 1006_CR122
  publication-title: Pharm Res
  doi: 10.1016/j.phrs.2018.07.019
– volume: 109
  start-page: 2567
  year: 2012
  ident: 1006_CR69
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1117792109
– volume: 40
  start-page: 448
  year: 2019
  ident: 1006_CR89
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgz060
– volume: 67
  start-page: 9704
  year: 2007
  ident: 1006_CR58
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-2099
– volume: 348
  start-page: 100
  year: 2014
  ident: 1006_CR51
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.03.006
– volume: 5
  start-page: 254
  year: 2004
  ident: 1006_CR4
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(04)01431-7
– volume: 6
  start-page: 250ra115
  year: 2014
  ident: 1006_CR97
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3009569
– volume: 341
  start-page: 1236361
  year: 2013
  ident: 1006_CR10
  publication-title: Science
  doi: 10.1126/science.1236361
– volume: 358
  start-page: 321
  year: 2017
  ident: 1006_CR13
  publication-title: Science
  doi: 10.1126/science.aah5072
– volume: 52
  start-page: 214
  year: 1998
  ident: 1006_CR63
  publication-title: Biomed Pharmacother
  doi: 10.1016/S0753-3322(98)80019-X
– volume: 74
  start-page: 418
  year: 2019
  ident: 1006_CR123
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2019.04.017
– volume: 31
  start-page: 342
  year: 2017
  ident: 1006_CR1
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.02.005
– volume: 2015
  start-page: 354957
  year: 2015
  ident: 1006_CR80
  publication-title: J Immunol Res
– volume: 29
  start-page: 2635
  year: 2011
  ident: 1006_CR29
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.33.5422
– volume: 29
  start-page: 881
  year: 2014
  ident: 1006_CR111
  publication-title: Histol Histopathol
– volume: 370
  start-page: 56
  year: 2016
  ident: 1006_CR85
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.09.018
– volume: 567
  start-page: 535
  year: 2019
  ident: 1006_CR124
  publication-title: Nature
  doi: 10.1038/s41586-019-1024-7
– volume: 153
  start-page: 277
  year: 2017
  ident: 1006_CR76
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2017.03.008
– volume: 285
  start-page: 35462
  year: 2010
  ident: 1006_CR18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.109579
– volume: 51
  start-page: 1244
  year: 2010
  ident: 1006_CR75
  publication-title: Hepatology
  doi: 10.1002/hep.23441
– volume: 55
  start-page: 55
  year: 2016
  ident: 1006_CR112
  publication-title: Neuropeptides
  doi: 10.1016/j.npep.2015.10.005
– volume: 54
  start-page: 283
  year: 2019
  ident: 1006_CR90
  publication-title: Int J Oncol
– volume: 33
  start-page: 3997
  year: 2019
  ident: 1006_CR20
  publication-title: FASEB J
  doi: 10.1096/fj.201801429RR
– volume: 33
  start-page: 75
  year: 2018
  ident: 1006_CR11
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.11.007
– volume: 23
  start-page: 38
  year: 2016
  ident: 1006_CR120
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0000000000000218
– volume: 6
  year: 2011
  ident: 1006_CR19
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0019246
– volume: 65
  start-page: 635
  year: 2014
  ident: 1006_CR24
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2013.01.007
– volume: 118
  start-page: 1380
  year: 2008
  ident: 1006_CR37
  publication-title: J Clin Investig
  doi: 10.1172/JCI33125
– volume: 12
  start-page: 602
  year: 2017
  ident: 1006_CR42
  publication-title: J NeuroImmune Pharmacol
  doi: 10.1007/s11481-017-9749-2
– volume: 66
  start-page: S139
  issue: Suppl 2
  year: 2017
  ident: 1006_CR99
  publication-title: Physiol Res
  doi: 10.33549/physiolres.933671
– volume: 186
  start-page: 3040
  year: 2016
  ident: 1006_CR117
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2016.07.019
– volume: 12
  start-page: 909
  year: 2011
  ident: 1006_CR113
  publication-title: Curr Drug Targets
  doi: 10.2174/138945011795528796
– volume: 22
  start-page: 260
  year: 2016
  ident: 1006_CR114
  publication-title: Saudi J Gastroenterol
  doi: 10.4103/1319-3767.187601
– volume: 142
  start-page: 144
  issue: Suppl 2
  year: 2017
  ident: 1006_CR87
  publication-title: J Neurochem
  doi: 10.1111/jnc.13953
– volume: 17
  year: 2018
  ident: 1006_CR91
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0901-2
– volume: 109
  start-page: 632
  year: 2007
  ident: 1006_CR44
  publication-title: Blood
  doi: 10.1182/blood-2006-01-028423
– volume: 7
  year: 2016
  ident: 1006_CR53
  publication-title: Nat Commun
  doi: 10.1038/ncomms10715
– volume: 15
  start-page: 62
  year: 2015
  ident: 1006_CR71
  publication-title: Curr Mol Med
  doi: 10.2174/1566524015666150114113411
– volume: 47
  start-page: 1546
  year: 2008
  ident: 1006_CR55
  publication-title: Acta Oncol
  doi: 10.1080/02841860801961265
– volume: 10
  start-page: 4349
  year: 2004
  ident: 1006_CR36
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-04-0059
– volume: 25
  start-page: 2566
  year: 2018
  ident: 1006_CR56
  publication-title: Curr Med Chem
  doi: 10.2174/0929867324666170303121708
– volume: 60
  start-page: 1225
  year: 2014
  ident: 1006_CR17
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.02.025
– volume: 16
  start-page: 804
  year: 2010
  ident: 1006_CR68
  publication-title: Nat Med
  doi: 10.1038/nm.2173
– volume: 168
  start-page: 461
  year: 2019
  ident: 1006_CR73
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2019.02.056
– volume: 29
  start-page: 2645
  year: 2011
  ident: 1006_CR30
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.33.4441
– volume: 151
  start-page: 1218
  year: 2016
  ident: 1006_CR40
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2016.08.040
– volume: 48
  start-page: 2258
  year: 2018
  ident: 1006_CR38
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000492644
– volume: 82
  start-page: 536
  year: 2008
  ident: 1006_CR57
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2007.12.014
– volume: 114
  start-page: 8
  year: 2019
  ident: 1006_CR72
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2019.03.017
– volume: 77
  start-page: 1611
  year: 2017
  ident: 1006_CR23
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-2143
– volume: 19
  start-page: 419
  year: 2016
  ident: 1006_CR6
  publication-title: Stress
  doi: 10.1080/10253890.2016.1203415
– volume: 68
  start-page: 1994
  issue: 11
  year: 2019
  ident: 1006_CR54
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-317479
– volume: 25
  start-page: 1631
  year: 2015
  ident: 1006_CR65
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2015.05.008
– volume: 7
  year: 2017
  ident: 1006_CR41
  publication-title: Sci Rep
  doi: 10.1038/srep45686
– volume: 161
  start-page: 481
  year: 2010
  ident: 1006_CR84
  publication-title: Br J Pharm
  doi: 10.1111/j.1476-5381.2010.00923.x
– volume: 7
  year: 2016
  ident: 1006_CR8
  publication-title: Nat Commun
– volume: 41
  start-page: 384
  year: 2018
  ident: 1006_CR34
  publication-title: Arch Pharm Res
  doi: 10.1007/s12272-018-1017-3
– volume: 177
  start-page: 646
  year: 2014
  ident: 1006_CR93
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2014.09.178
– volume: 134
  start-page: 1
  year: 2017
  ident: 1006_CR98
  publication-title: J Pharm Sci
  doi: 10.1016/j.jphs.2017.05.002
– volume: 202
  start-page: 38
  year: 2018
  ident: 1006_CR86
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2018.07.006
– volume: 28
  start-page: 1836
  year: 2017
  ident: 1006_CR26
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx264
– volume: 8
  start-page: 7
  year: 2013
  ident: 1006_CR5
  publication-title: J NeuroImmune Pharmacol
  doi: 10.1007/s11481-012-9395-7
– volume: 124
  start-page: 775
  year: 2017
  ident: 1006_CR108
  publication-title: J Neural Transm
  doi: 10.1007/s00702-016-1661-z
– volume: 29
  start-page: 859
  year: 2016
  ident: 1006_CR39
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.05.002
– volume: 34
  start-page: 2711
  year: 2015
  ident: 1006_CR106
  publication-title: Oncogene
  doi: 10.1038/onc.2014.231
– volume: 215
  start-page: 17
  year: 2018
  ident: 1006_CR107
  publication-title: J Exp Med
  doi: 10.1084/jem.20172050
– volume: 97
  start-page: 191
  year: 2015
  ident: 1006_CR43
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.5A1113-626RR
– volume: 2
  start-page: 215
  year: 2015
  ident: 1006_CR116
  publication-title: Regen Biomater
  doi: 10.1093/rb/rbv013
– volume: 140
  start-page: 513
  year: 2017
  ident: 1006_CR66
  publication-title: Int J Cancer
  doi: 10.1002/ijc.30443
– volume: 19
  start-page: 655
  year: 2008
  ident: 1006_CR59
  publication-title: Anticancer drugs
  doi: 10.1097/CAD.0b013e3283025b58
– volume: 11
  start-page: 408
  year: 2009
  ident: 1006_CR78
  publication-title: Neoplasia
  doi: 10.1593/neo.81630
SSID ssj0007902
Score 2.6383815
SecondaryResourceType review_article
Snippet Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the stimulatory or inhibitory neuronal functions through binding to their...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 503
SubjectTerms 13/21
38/39
42/47
45/41
631/67/327
631/80/86/2363
Angiogenesis
Animals
Antineoplastic Agents - therapeutic use
Antitumor activity
Apoptosis
B cells
Cancer
Carcinogenesis - drug effects
Carcinogenesis - pathology
Cell Biology
Cell proliferation
Development and progression
Disease Models, Animal
Endothelial cells
Human Genetics
Humans
Inflammation
Inflammation - drug therapy
Inflammation - immunology
Inflammation - pathology
Internal Medicine
Medicine
Medicine & Public Health
Mice
Neoplasms - blood supply
Neoplasms - drug therapy
Neoplasms - immunology
Neoplasms - pathology
Neovascularization, Pathologic - drug therapy
Neovascularization, Pathologic - immunology
Neovascularization, Pathologic - pathology
Neurophysiology
Neurotransmitter Agents - antagonists & inhibitors
Neurotransmitter Agents - metabolism
Neurotransmitters
Oncology
Physiological aspects
Receptors, Neurotransmitter - antagonists & inhibitors
Receptors, Neurotransmitter - metabolism
Review Article
Signal transduction
Signal Transduction - drug effects
Tumor Microenvironment - drug effects
Tumor Microenvironment - immunology
Tumorigenesis
Title Neurotransmitters: emerging targets in cancer
URI https://link.springer.com/article/10.1038/s41388-019-1006-0
https://www.ncbi.nlm.nih.gov/pubmed/31527667
https://www.proquest.com/docview/2343175755
https://www.proquest.com/docview/2292997769
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-6lm57GV22bl4_8KAw2BC1JVuy-jKS0FAGDaOskDdhSzIUWqdr0of997uz5bQptC_2gz6QT9LdT77T_QCOdJo7tKuCKWk5y-rEsSL3GfM69U7mVus22_75VJ5dZr9m-Sz8cFuEsMpeJ7aK2s0t_SM_5qI1dSrPf97-ZcQaRd7VQKHxCrYodRmFdKnZ6sCVqC7mEFFEwhDI8N6rKYrjBSrvgsK4NCoiOlSv2aWn2vmReXriL23N0GQH3gX8GA-7CX8PG74ZwHbHKPlvAG_GPYHbAF6fB7_5B-hycCzJLt1ctQk1T2K6GUwMRXEXDL6Ir5rY0hq4-wiXk9M_4zMWiBKYRTyxZKn3ea1VUlWZTkRecyeLUhBW49yJWlg8JIpaycrik2fK-SyxaZmlliMCUV7swmYzb_xniD0CHqeqitfcElarygr3eFZKZzWl8osg6cVkbMgiTmQW16b1ZovCdJI1KFnKhywNNvm-anLbpdB4qfI3kr2h7YX92jLcEsDRUaIqM5R0jRons4hgf60mCteuF_ezZ8K2XJiHRRTB11UxtaRQs8bP77EOR8SIqFjqCD51s74atiASYClVBD_6ZfDQ-bPf9OXloezBW06H-IQYu_dhc3l37w8Q6Syrw3Y547MYp4ewNZyMRlN8j06nvy_-A0Bg9w4
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3faxQxEB7qFa0vouev1aorKIISupvsJhtBpNaWq-0dIi30Le4mWSjoXu1dkf5T_o3ObHavXsG-9WVfNgnZyex8k8xkPoBXOs0d4qpgSlrOsjpxrMh9xrxOvZO51bqttj-eyNFh9uUoP1qBP_1dGEqr7G1ia6jd1NIZ-QYXLdSpPP948osRaxRFV3sKjaAWe_78N27ZZh92P-P6vuZ8Z_tga8Q6VgFmEXznLPU-r7VKqirTichr7mRRCnJsOHeiFhZ3VKJWsrL45JlyPktsWmap5QjXygsc9wasZgK3MgNY_bQ9-fptYftVyHJEvyVh6DrxPo4qio0ZwkVBiWMaTR9t45eQ8DIe_AOIlyK0LfDt3IU7nccabwYVuwcrvhnCzcBheT6Eta2eMm4It8ZdpP4-hKofc0LCn8dtCc_3Md1FJk6kOKSfz-LjJrakdacP4PBahPgQBs208Y8h9uhiOVVVvOaWvMOqrNCqZKV0VlPxwAiSXkzGdnXLiT7jh2nj56IwQbIGJUsVmKXBLm8XXU5C0Y6rGr8h2Rv6oXFcW3b3EnB2VBrLbEq6uI2LWUSwvtQShWuXX_erZzpDMDMXahvBy8Vr6knJbY2fnmEbjj4q-uFSR_AorPpi2oJoh6VUEbzr1eBi8P9-05Orp_IC1kYH432zvzvZewq3OR0hJMQXvg6D-emZf4Z-1rx63il3DN-v-3_6C-G7MA8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1RTxQxEJ4gRvSF6Cm6iromGhNJc7vttt0lMYaAFxAhPkhyb2W37SYksIfcEcNf89c5s909PBJ542Vftm260-l8053pfADvi1Q6xFXBtLKcZXXiWC59xnyReqekLYq22v7Bodo9yr6N5XgJ_vR3YSitsreJraF2E0v_yIdctFCnpRzWXVrEj53Rl_NfjBikKNLa02kEFdn3V7_x-Db9vLeDa_2B89HXn9u7rGMYYBaBeMZS72Vd6KSqsiIRsuZO5aUgJ4dzJ2ph8XQlaq0qi0-eaeezxKZlllqO0K29wHHvwX0tZEp7TI_nh71Eh3xH9GAShk4U7yOqIh9OEThySiEr0AjSgX4BE28iwz_QeCNW20Lg6DGsdr5rvBWU7Qks-WYADwKb5dUAHm735HEDWDnoYvZPIdT_mBEmnp20xTw3Y7qVTOxIcUhEn8YnTWxJ_y6ewdGdiHANlptJ419A7NHZcrqqeM0t-YlVWaF9yUrlbEFlBCNIejEZ21UwJyKNU9NG0kVugmQNSpZqMSuDXT7Nu5yH8h23Nf5Isje0tXFcW3Y3FHB2VCTLbCm6wo2LmUewvtAShWsXX_erZzqTMDXXChzBu_lr6klpbo2fXGIbjt4qeuSqiOB5WPX5tAURECulI9jo1eB68P9-08vbp_IWVnAXme97h_uv4BGnfwkJEYevw_Ls4tK_RodrVr1pNTuG47veSn8BLaYy3w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurotransmitters%3A+emerging+targets+in+cancer&rft.jtitle=Oncogene&rft.au=Jiang%2C+Shu-Heng&rft.au=Hu%2C+Li-Peng&rft.au=Wang%2C+Xu&rft.au=Li%2C+Jun&rft.date=2020-01-16&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.volume=39&rft.issue=3&rft.spage=503&rft_id=info:doi/10.1038%2Fs41388-019-1006-0&rft.externalDocID=A611469238
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon